Swiss National Bank
NAVB

Swiss National Bank’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Swiss National Bank’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,150
Closed -$215K – 2594
2014
Q3 		$215K Hold
8,150
– – ﹤0.01% 2420
2014
Q2 		$241K Hold
8,150
– – ﹤0.01% 2437
2014
Q1 		$302K Buy
8,150
+1,700
+26% +$64.5K ﹤0.01% 2327
2013
Q4 		$267K Hold
6,450
– – ﹤0.01% 2313
2013
Q3 		$342K Buy
6,450
+535
+9% +$31.2K ﹤0.01% 2160
2013
Q2 		$316K Buy
+5,915
New +$295K ﹤0.01% 2190

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Swiss National Bank's NAVB Position: Q4 2014 in Review

Swiss National Bank sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2014, closing a stake of 8,150 shares — an estimated $215K sold.

Swiss National Bank first reported a position in NAVB in Q2 2013 and held it in 6 quarters. The position peaked at $342K in Q3 2013. 87 funds tracked by Wall St. Rank hold NAVB as of Q4 2014.

  • Swiss National Bank reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • Swiss National Bank sold 8,150 Navidea Biopharmaceuticals Inc. shares in Q4 2014, an estimated $215K.
  • Swiss National Bank first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 6 quarters.
  • Swiss National Bank's Navidea Biopharmaceuticals Inc. position peaked at $342K in Q3 2013.
  • 87 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2014.

Based on Swiss National Bank's 13F filing for Q4 2014, filed 3 Feb 2015.